Heartfulness Institute Fond

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  2.0% 2.0% 2.0% 2.0% 2.0%  
Bankruptcy risk  14.3% 14.6% 17.1% 11.7% 10.8%  
Credit score (0-100)  15 13 9 19 23  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -15.0 -10.5 -17.3 -15.1 -13.6  
EBITDA  -15.0 -10.5 -17.3 -15.1 -13.6  
EBIT  -29.0 -24.5 -31.3 -15.1 -13.6  
Pre-tax profit (PTP)  -29.6 -26.4 -33.2 -15.1 -13.6  
Net earnings  -29.6 -26.4 -33.2 -15.1 -13.6  
Pre-tax profit without non-rec. items  -29.6 -26.4 -33.2 -15.1 -13.6  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  28.0 14.0 0.0 0.0 0.0  
Shareholders equity total  373 347 314 299 285  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  383 357 324 309 295  

Net Debt  -281 -268 -248 -233 -220  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -15.0 -10.5 -17.3 -15.1 -13.6  
Gross profit growth  18.9% 30.3% -65.1% 12.5% 10.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  383 357 324 309 295  
Balance sheet change%  -8.3% -6.9% -9.3% -4.7% -4.4%  
Added value  -15.0 -10.5 -17.3 -1.1 -13.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -28 -28 -28 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  193.3% 233.9% 181.1% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -7.2% -6.6% -9.2% -4.8% -4.5%  
ROI %  -7.5% -6.8% -9.5% -4.9% -4.6%  
ROE %  -7.6% -7.3% -10.0% -4.9% -4.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  97.4% 97.2% 96.9% 96.8% 96.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,870.8% 2,566.0% 1,439.2% 1,544.1% 1,619.8%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  30.5 29.3 27.4 25.9 24.5  
Current Ratio  30.5 29.3 27.4 25.9 24.5  
Cash and cash equivalent  280.7 268.3 248.4 233.3 219.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  295.3 282.9 263.8 248.6 235.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0